W.R. Berkley Q4 EPS Misses Estimate, Reports $3.72B Revenue and 19% Upside Target
W.R. Berkley reported Q4 EPS of $1.13, missing the $1.14 consensus by 0.59%, and posted $3.72B in revenue, up from $3.51B year-over-year but 0.94% below estimates. Truist Financial established an $80 price target, implying 19.24% upside and reflecting confidence in the insurer's growth trajectory.
1. Q4 Earnings and EPS Surprise
W. R. Berkley reported quarterly earnings per share of $1.13, missing the Zacks Consensus Estimate of $1.14 by 0.59%. This result mirrored the same-quarter EPS from the prior year and represents the company’s third close miss in the past four quarters. Despite the slight shortfall, the company maintained strong underwriting discipline, supported by favorable loss ratios in its specialty lines.
2. Revenue and Premium Growth
For the quarter ending December 2025, W. R. Berkley generated $3.72 billion in revenue, up from $3.51 billion in the year-earlier period but 0.94% below consensus estimates. Gross premiums written for the full year reached $15.1 billion, a 6.3% increase over 2024’s $14.2 billion, while net premiums written climbed to $12.7 billion from $12.0 billion a year ago. These figures underscore the company’s consistent growth in both top-line revenue and core underwriting volumes.
3. Valuation Metrics Reflect Market Position
The company’s current price-to-earnings ratio stands at 13.94, with a price-to-sales ratio of 1.73. Enterprise value to sales is approximately 1.76, and enterprise value to operating cash flow is 7.61, highlighting a balanced valuation relative to peers. An earnings yield of 7.17% and a debt-to-equity ratio of 0.29 further illustrate W. R. Berkley’s strong profitability and conservative leverage profile, factors that support its credit ratings and borrowing costs.
4. Analyst Outlook and Price Target
Truist Financial has set a price target of $80 for W. R. Berkley, implying a potential upside of 19.24% from recent levels. This bullish outlook is driven by expectations of continued premium growth, stable combined ratios, and record investment income. Investors will be watching the company’s ability to sustain underwriting margins and capitalize on favorable market conditions in specialty and casualty lines.